Shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Free Report ) hit a new 52-week high on Thursday. The stock traded as high as $149.27 and most recently at $147.34 on trading volume of 305251 shares. The stock last closed at $145.65.
iShares Biotechnology ETF Price Performance
The stock’s 50 day moving average price is $138.74 and its 200 day moving average price is $135.97.
Institutional investor inflows and outflows
Several institutional investors recently modified their positions in the business. International Assets Investment Management LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth $76,425,000. Global Assets Advisory LLC acquired a new stake in iShares Biotechnology ETF in the first quarter worth approximately $66,059,000. BNP Paribas Financial Markets increased its holdings in iShares Biotechnology ETF by 25.7% in the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock, valued at $282,038,000, after purchasing an additional 420,053 shares in the last quarter. Gray Foundation acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $17,890,000. Finally, Jane Street Group LLC bought a new position in iShares Biotechnology ETF in the first quarter worth about $14,386,000. Hedge funds and other institutional investors now own 62.45% of the company’s shares.
iShares Biotechnology ETF Company Profile
(Get your free report)
iShares Nasdaq Biotechnology ETF (the Fund) is an exchange-traded fund (ETF) formerly known as iShares Nasdaq Biotechnology Index Fund. The Fund seeks to achieve investment results that generally correspond to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index includes securities of NASDAQ-listed companies that are classified as biotechnology or pharmaceutical pursuant to an industry classification benchmark and also meet other eligibility criteria established by NASDAQ.
Feature Articles
Get iShares Biotechnology ETF News and Ratings Daily – Enter your email address below to receive a concise summary of the latest news and analyst ratings on iShares Biotechnology ETF and related companies every day in MarketBeat.com’s free email newsletter.
